Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMC Delivery Strategies for Severe Anaemia in Malawi
NCT02721420Phase 3Unknown
- Start
- Mar 2016
- Primary completion
- Mar 2019
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in malaria. Status: unknown.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02721420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02721420.